Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:5UM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 16.18 Med: 19.62 Max: 28.51
Current: 17.19
During the past 12 years, the highest EV-to-EBITDA of Genertec Universal Medical Group Co was 28.51. The lowest was 16.18. And the median was 19.62.
FRA:5UM's EV-to-EBITDA is ranked better than 55.59% of 322
companies
in the Credit Services industry
Industry Median: 20.575
vs FRA:5UM: 17.19
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Genertec Universal Medical Group Co (FRA:5UM) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Genertec Universal Medical Group Co's PE Ratio (TTM) for today is calculated as:
Genertec Universal Medical Group Co's share price for today is €0.498.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genertec Universal Medical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.131.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genertec Universal Medical Group Co EV-to-EBITDA Chart
For the Credit Services subindustry, Genertec Universal Medical Group Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genertec Universal Medical Group Co EV-to-EBITDA vs Credit Services Industry
For the Credit Services industry and Financial Services sector, Genertec Universal Medical Group Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Genertec Universal Medical Group Co's EV-to-EBITDA falls into.
Genertec Universal Medical Group Co's current Enterprise Value is €8,029 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genertec Universal Medical Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €469 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genertec Universal Medical Group Co (FRA:5UM) has a EV-to-EBITDA of 17.12 as of Sep. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Genertec Universal Medical Group Co. This is 13% below median its historical median of 19.62. Over the past decade, Genertec Universal Medical Group Co's EV-to-EBITDA has ranged from 16.18 to 28.51. According to the industry distribution chart, Genertec Universal Medical Group Co ranks #143 out of 322 companies in the Credit Services industry, placing it in the top 44.4%.
Is Genertec Universal Medical Group Co's EV-to-EBITDA too high?
Genertec Universal Medical Group Co's current EV-to-EBITDA of 17.12 is 13% below median its 10-year median of 19.62. Over the past 10 years, this metric has ranged from a low of 16.18 to a high of 28.51. The Credit Services industry median EV-to-EBITDA is 20.58. Genertec Universal Medical Group Co's value of 17.12 is 16.8% below this industry median. Based on the distribution chart, Genertec Universal Medical Group Co ranks #143 out of 322 companies in the Credit Services industry, which is above the industry midpoint. Overall, Genertec Universal Medical Group Co has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genertec Universal Medical Group Co's EV-to-EBITDA compare to V and MA?
According to the Credit Services industry distribution chart, Genertec Universal Medical Group Co ranks #143 out of 322 companies for EV-to-EBITDA. This puts Genertec Universal Medical Group Co in the upper half of its industry. The industry median EV-to-EBITDA is 20.58. Genertec Universal Medical Group Co's value of 17.12 is 16.8% below this benchmark. Historically, Genertec Universal Medical Group Co's own EV-to-EBITDA has ranged from 16.18 to 28.51 over the past decade. While the company's 10-year median is 19.62 vs. the industry median of 20.58, Genertec Universal Medical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Credit Services company?
The median EV-to-EBITDA among Credit Services companies is 20.58, based on 322 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genertec Universal Medical Group Co's current EV-to-EBITDA of 17.12 is 16.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Genertec Universal Medical Group Co. For the Credit Services industry, the median EV-to-EBITDA is 20.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genertec Universal Medical Group Co's current EV-to-EBITDA is 17.12, which is 13% below median its own 10-year median of 19.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genertec Universal Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co (FRA:5UM) is currently considered Fairly Valued. The stock's GF Value™ is €0.46, compared to a current price of €0.50 — trading 8.3% above its estimated fair value. The current EV-to-EBITDA is 17.12, which is 13% below median its 10-year median of 19.62 and 16.8% below the Credit Services industry median of 20.58. Genertec Universal Medical Group Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Genertec Universal Medical Group Co (FRA:5UM), the current EV-to-EBITDA is 17.12 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genertec Universal Medical Group Co (FRA:5UM) Overvalued in 2026?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co stock appears to be overvalued.
The current stock price of €0.50 is trading 8.3% above its estimated GF Value™ of €0.46.
GuruFocus considers Genertec Universal Medical Group Co to be Fairly Valued.
Key valuation signals for FRA:5UM:
EV-to-EBITDA: 17.12 (13% below median its 10-year median of 19.62)
GF Value™: €0.46 vs. price of €0.50 (8.3% above fair value)
Industry Position: 16.8% below the Credit Services median (#143 of 322)
No single metric tells the full story. See the FRA:5UM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The group has two business segments namely The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services; and Healthcare business comprises includes hospital group business, healthcare technology business and specialty business. Geographically, it derives a majority of its revenue from Mainland China.
48GF Score
Get the complete analysis for FRA:5UM
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5UM has been successfully added to your 
